Wildlife Health Market Size, Share, Opportunities, And Trends By Animal Type (Mammals, Birds, Fish, Reptiles, Amphibians), By Product (Medicine, Equipment & Consumables), By Route Of Administration (Oral, Injectable, Others), By End-User (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others), And By Geography - Forecasts From 2024 To 2029

  • Published : Jan 2024
  • Report Code : KSI061616557
  • Pages : 147

The wildlife health market is predicted to show substantial growth during the forecast period.

The holistic health of wild animals in their native habitats is referred to as wildlife health. Wildlife health is greatly dependent on the condition of a habitat, which is impacted by things like pollution, climate change, and human activity. The general well-being of animals is greatly impacted by human interactions, both positive (conservation initiatives) and bad (hunting, habitat loss). Genetic variety is essential for population resilience, illness prevention, and environmental adaptation. Frequent research and monitoring efforts help to understand the health of animals, which makes it easier to establish conservation measures.

Growth drivers for the wildlife health market

Concerns over the loss of species and a growing worldwide understanding of the value of ecosystems and biodiversity have strengthened support for wildlife health programs, boosting the wildlife health market. Adaptive techniques are required due to the effects of climate change on animal habitats and migration patterns, while technical breakthroughs such as genetic analysis and remote sensing offer advanced tools for monitoring and treating health concerns in wild populations. The One Health concept encourages cross-sector collaboration by acknowledging the interdependence of environmental, animal, and human health. Funding for wildlife health programs is also provided by government legislation, conservation-focused policies, and Corporate Social Responsibility (CSR) activities.

Increased awareness and concern for biodiversity

The wildlife health industry receives financing and investments due to growing public knowledge and concern for biodiversity, which in turn spurs business activities, policy reform, and research. A more knowledgeable public encourages participation, which develops specialized services and a cooperative global strategy to solve issues related to wildlife health. The creation of sustainable practices and regulations for the preservation of wildlife and their habitats is aided by this increased awareness of global issues. For instance, to support the preservation, sustainable use, and restoration of biodiversity in Mexico, the Mexican Partnership for Business and Biodiversity (AMEBIN), encourages communication and collaboration between the commercial sector and civil society organizations.

One health approach

Collaboration between the human, animal, and environmental health sectors is fostered by the One Health strategy, which has a substantial influence on the wildlife health industry. The World Health Organisation (WHO), the Food and Agriculture Organisation (FAO), the United Nations Environment Programme (UNEP), and the World Organisation for Animal Health (WOAH), which together form the Quadripartite, recognized the significance of a concerted global effort and thus launched the One Health Joint Plan of Action 2022–2026. This extensive five-year program aims to promote cross-sector cooperation and coordination to address health risks that affect people, animals, plants, and the environment.

Conservation and ecotourism

Ecotourism and conservation are major factors influencing the wildlife health sector. Conservation activities have an influence on financing, research, and policy development in the field of wildlife health by helping to preserve ecosystems and safeguard wildlife. The public's fascination with wildlife drives ecotourism, which creates economic value and encourages funding for programs aimed at improving the health of animals. When combined, conservation and ecotourism support environmentally friendly behaviors and help to expand specialized services, which in turn creates a vibrant market for the health of animals.

Disease Surveillance and Zoonotic Concerns

The wildlife health market is greatly impacted by disease surveillance and zoonotic problems, which highlight the importance of proactive monitoring and control. Increasing focus on zoonotic diseases motivates funding increases for wildlife health initiatives to stop spillover incidents. The development of specialized services and technology within the wildlife health sector is influenced by the necessity of surveillance activities to monitor illnesses in animal populations. By addressing public health issues and encouraging the sustainable cohabitation of wildlife and human populations, this emphasis on disease prevention and management improves overall market dynamics. To better protect human and animal health, the World Organisation for Animal Health (WOAH, formerly OIE) advises the establishment of national, coordinated wildlife health surveillance (WHS) programs. These programs are designed to manage pathogen-related issues in wildlife and provide information for disease management.

Birds under the animal type segment are anticipated to grow significantly

The bird health products market is driven by several factors that represent the different demands of bird populations. Growing trends in the ownership of companion birds are driving up demand for specialized items and veterinary treatment. With an emphasis on disease control and flock health, the market is stimulated by the poultry industry's development. Moreover, emerging zoonotic dangers impact the development of vaccines and diagnostics by emphasizing the value of research and surveillance. The bird health market is further shaped by environmental effects, governmental laws, and concerns about international commerce, all of which highlight the significance of avian medical research, and advancements.

Prominent market growth is anticipated in the North American region

The North American wildlife health market is driven by several reasons that are indicative of the region's dedication to biodiversity and conservation. The industry is growing because of public and corporate backing, which includes investment from socially aware companies and individuals who care about the environment. Advanced diagnostics and monitoring technologies are in high demand due to ongoing research into wildlife illnesses as well as the necessity for disease surveillance and management in the face of zoonotic risks. The wildlife health industry is shaped in part by habitat preservation and restoration efforts, technological developments, and the effects of climate change on ecosystems.

Market Key Developments

  • In August 2023, the introduction of NexGard® (afoxolaner) S and M in India was announced by Boehringer Ingelheim, a leading worldwide player in the fields of human and animal health. This growth of the NexGard® product range for small dogs (2-4 kg) and medium dogs (4-10 kg) follows the well-received release of NexGard® X and L earlier in 2020.
  • In August 2023, the debut of FALCON® Biomass, a potent, always-on biomass estimate unit that offers crucial information regarding average weight, distribution, and growth patterns to optimize fish farming operations, was announced by MSD Animal Health, a part of Merck & Co., Inc., Rahway, N.J., USA.
  • In April 2022, a leading global provider of animal health care, Elanco Animal Health Incorporated, along with Ginkgo Bioworks, the industry's top horizontal platform for cell programming, announced the establishment of BiomEdit, a microbiome innovation company that plans to find, develop, and market innovative probiotics, bioactive compounds, engineered microbial medicines, and microbial monitoring services for animal health.


  • By Animal Type
    • Mammals
    • Birds
    • Fish
    • Reptiles
    • Amphibians
  • By Product
    • Medicine
    • Equipment & Consumables
  • By Route of Administration
    • Oral
    • Injectable
    • Others
  • By End-User
    • Zoos
    • Wildlife Sanctuaries
    • Wildlife Rescue & Rehab Centers
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Mammals

5.3. Birds

5.4. Fish

5.5. Reptiles

5.6. Amphibians


6.1. Introduction

6.2. Medicine

6.3. Equipment & Consumables


7.1. Introduction

7.2. Oral

7.3. Injectable

7.4. Others


8.1. Introduction

8.2. Zoos

8.3. Wildlife Sanctuaries

8.4. Wildlife Rescue & Rehab Centers

8.5. Others


9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. The Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand


10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations


11.1. Zoetis

11.2. Elanco

11.3. Alivira Animal Health (Sequent Scientific Limited)

11.4. Eco Animal Health

11.5. Vivaldis

11.6. MSD Animal Health

11.7. Boehringer Ingelheim

11.8. Ceva Sante Animale

11.9. Pfizer



Alivira Animal Health (Sequent Scientific Limited)

Eco Animal Health


MSD Animal Health

Boehringer Ingelheim

Ceva Sante Animale